PharmaState Is Official Media Partner For DUPHAT 2022. Click the banner to explore more...spot_imgspot_imgspot_img

Classification of Impurities

-

Impurities can be classified into the following categories:

  1. Organic Impurities (Process And Drug-Related)
  2. Inorganic Impurities
  3. Residual Solvents
  1. Organic Impurities :

Organic impurities can arise during the manufacturing process and/or storage of the new drug substance.

They can be identified or unidentified, volatile or non-volatile, and include:  

  • Starting materials
  • By-products
  • Intermediates
  •  Degradation products
  •  Reagents, ligands and catalysts

2. Inorganic Impurities:

  • Inorganic impurities can result from the manufacturing process.
  • They are normally known and identified and include:
    • Reagents, ligands and catalysts
      • Heavy metals or other residual metals
      • Inorganic salts
      • Other materials (e.g., filter aids, charcoal)

3. Residual Solvents:

  • Residual are inorganic or organic liquids used as vehicles for the preparation of solutions or suspensions in the synthesis of a new drug substance.

3.1 Classification of Residual Solvents by Risk Assessment

a. Class 1 Solvents : Solvents to be avoided

  • Solvents in Class 1 should not be employed in the manufacture of drug substances, excipients, and drug products because of their unacceptable toxicity or their deleterious environmental effect.
  • However, if their use is unavoidable in order to produce a drug product with a significant therapeutic advance, then their levels should be restricted as shown in Table.

-Known human carcinogens

-Strongly suspected human carcinogens,

-Environmental hazards.

b. Class 2 solvents: Solvents To Be Limited

  • Solvents in Table should be limited in pharmaceutical products because of their inherent toxicity.
  • PDE*s are given to the nearest 0.1 mg/day, and concentrations are given to the nearest 10 ppm.

-Non-genotoxic animal carcinogens

-Possible causative agents of other irreversible toxicity such as neurotoxicity or teratogenicity.

-Solvents suspected of other significant but reversible toxicities.

c. Class 3 Solvents: Solvents With Low Toxic Potential

  • Solvents in Class 3 may be regarded as less toxic and of lower risk to human health.
  • Class 3 includes no solvent known as a human health hazard at levels normally accepted in pharmaceuticals.

-Solvents with low toxic potential to man; no health-based exposure limit is needed.

-Class 3 solvents have PDEs of 50 mg or more per day

3.2 Solvents for which No Adequate Toxicological Data was Found

* PDE: Permitted Daily Exposure is the maximum acceptable intake per day of residual solvent in pharmaceutical products.

Reference : ICH Q3 

For any feedback or suggestions write to us at info@pharmastate.com

Share this:

PharmaState Blog
This is a platform for people working in the pharmaceuticals industry for Discussions, Jobs, News updates, Professional Profile display space and company business pages. PharmaState DNA is having four pillars: Quality, Transparency, Innovation & Benchmarks.

Share this article

Recent posts

Popular categories

Leave a Reply

Recent comments

Business Alnavedic on History of Indian Pharma Industry
Ahmed Mohamed Elkhodragy on MACO Calculation
Jennifer Osunde on DEFECTS IN UNCOATED TABLETS
Vinod on DEVIATION
Rajib ghose on TOOLING FOR TABLETING
K. SRinivasula Reddy on Quality Agreements – PART 2
Sunil Kumar M on SITE ACCEPTANCE TEST (SAT)
Khalid on IQ Protocol
Khalid on IQ Protocol
Nagabooshanam on Calibration of Reactor
PharmaState Blog on SOP for Sampling
Swapnil Khodake on TOOLING FOR TABLETING
%d bloggers like this: